| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.894 | 0.004 | 0.897 | Antiadrenergic | 0.896 0.004 DBMET00115 0.85 0.004 DBMET00116 0.85 0.004 DBMET00117 0.897 0.004 DBMET00118 0.896 0.004 DBMET00119 0.234 0.019 DBMET02722 | DBMET00118 | |
| 0.893 | 0.004 | 0.897 | Adrenaline antagonist | 0.896 0.004 DBMET00115 0.849 0.004 DBMET00116 0.849 0.004 DBMET00117 0.897 0.004 DBMET00118 0.896 0.004 DBMET00119 0.232 0.019 DBMET02722 | DBMET00118 | |
| 0.84 | 0.003 | 0.877 | Vasodilator, peripheral | 0.877 0.003 DBMET00115 0.83 0.003 DBMET00116 0.83 0.003 DBMET00117 0.839 0.003 DBMET00118 0.877 0.003 DBMET00119 0.755 0.004 DBMET02722 | DBMET00119 | |
| 0.699 | 0.007 | 0.699 | 5 Hydroxytryptamine release stimulant | 0.604 0.014 DBMET00115 0.67 0.009 DBMET00116 0.67 0.009 DBMET00117 0.658 0.01 DBMET00118 0.604 0.014 DBMET00119 0.454 0.035 DBMET02722 | ||
| 0.661 | 0.005 | 0.664 | Cardiotonic | 0.613 0.007 DBMET00115 0.61 0.007 DBMET00116 0.61 0.007 DBMET00117 0.664 0.005 DBMET00118 0.613 0.007 DBMET00119 0.324 0.047 DBMET02722 | DBMET00118 | |
| 0.58 | 0.002 | 0.774 | Beta adrenoreceptor antagonist | 0.774 0.001 DBMET00115 0.666 0.002 DBMET00116 0.666 0.002 DBMET00117 0.696 0.001 DBMET00118 0.774 0.001 DBMET00119 0.087 0.023 DBMET02722 | DBMET00119 | |
| 0.586 | 0.008 | 0.683 | Vasodilator, coronary | 0.502 0.015 DBMET00115 0.586 0.008 DBMET00116 0.586 0.008 DBMET00117 0.562 0.01 DBMET00118 0.502 0.015 DBMET00119 0.683 0.005 DBMET02722 | DBMET02722 | |
| 0.548 | 0.018 | 0.596 | Spasmolytic | 0.54 0.019 DBMET00115 0.591 0.014 DBMET00116 0.591 0.014 DBMET00117 0.596 0.013 DBMET00118 0.54 0.019 DBMET00119 0.453 0.03 DBMET02722 | DBMET00118 | |
| 0.532 | 0.005 | 0.532 | Alpha adrenoreceptor antagonist | 0.519 0.005 DBMET00115 0.433 0.008 DBMET00116 0.433 0.008 DBMET00117 0.442 0.008 DBMET00118 0.519 0.005 DBMET00119 | ||
| 0.526 | 0.01 | 0.552 | Vasodilator | 0.504 0.012 DBMET00115 0.519 0.01 DBMET00116 0.519 0.01 DBMET00117 0.552 0.008 DBMET00118 0.504 0.012 DBMET00119 0.508 0.011 DBMET02722 | DBMET00118 | |
| 0.509 | 0.002 | 0.649 | Beta 1 adrenoreceptor antagonist | 0.649 0.001 DBMET00115 0.531 0.002 DBMET00116 0.531 0.002 DBMET00117 0.586 0.001 DBMET00118 0.649 0.001 DBMET00119 0.057 0.038 DBMET02722 | DBMET00119 | |
| 0.486 | 0.002 | 0.608 | Beta 3 adrenoreceptor antagonist | 0.608 0.001 DBMET00115 0.509 0.001 DBMET00116 0.509 0.001 DBMET00117 0.558 0.001 DBMET00118 0.608 0.001 DBMET00119 0.071 0.032 DBMET02722 | DBMET00119 | |
| 0.499 | 0.033 | 0.615 | Aldehyde oxidase inhibitor | 0.413 0.045 DBMET00115 0.615 0.017 DBMET00116 0.615 0.017 DBMET00117 0.566 0.024 DBMET00118 0.413 0.045 DBMET00119 | DBMET00117 | |
| 0.468 | 0.01 | 0.468 | P-glycoprotein inhibitor | 0.4 0.016 DBMET00115 0.452 0.011 DBMET00116 0.452 0.011 DBMET00117 0.436 0.013 DBMET00118 0.4 0.016 DBMET00119 0.246 0.042 DBMET02722 | ||
| 0.456 | 0.005 | 0.456 | Alpha 1 adrenoreceptor antagonist | 0.431 0.006 DBMET00115 0.352 0.008 DBMET00116 0.352 0.008 DBMET00117 0.33 0.009 DBMET00118 0.431 0.006 DBMET00119 | ||
| 0.449 | 0.002 | 0.601 | Beta 2 adrenoreceptor antagonist | 0.601 0.001 DBMET00115 0.52 0.002 DBMET00116 0.52 0.002 DBMET00117 0.574 0.001 DBMET00118 0.601 0.001 DBMET00119 0.056 0.028 DBMET02722 | DBMET00119 | |
| 0.502 | 0.059 | 0.591 | Caspase 9 stimulant | 0.44 0.088 DBMET00115 0.591 0.037 DBMET00116 0.591 0.037 DBMET00117 0.496 0.061 DBMET00118 0.44 0.088 DBMET00119 0.484 0.066 DBMET02722 | DBMET00117 | |
| 0.456 | 0.018 | 0.489 | DNA damaging | 0.489 0.015 DBMET00115 0.481 0.016 DBMET00116 0.481 0.016 DBMET00117 0.471 0.017 DBMET00118 0.489 0.015 DBMET00119 0.449 0.019 DBMET02722 | DBMET00119 | |
| 0.434 | 0.014 | 0.434 | Calcium channel activator | 0.375 0.035 DBMET00115 0.412 0.02 DBMET00116 0.412 0.02 DBMET00117 0.368 0.039 DBMET00118 0.375 0.035 DBMET00119 0.25 0.147 DBMET02722 | ||
| 0.403 | 0.003 | 0.544 | Adrenaline agonist | 0.544 0.002 DBMET00115 0.458 0.002 DBMET00116 0.458 0.002 DBMET00117 0.514 0.002 DBMET00118 0.544 0.002 DBMET00119 | DBMET00119 | |
| 0.408 | 0.015 | 0.421 | Cyclic AMP phosphodiesterase inhibitor | 0.375 0.02 DBMET00115 0.421 0.014 DBMET00116 0.421 0.014 DBMET00117 0.416 0.014 DBMET00118 0.375 0.02 DBMET00119 0.37 0.021 DBMET02722 | DBMET00117 | |
| 0.397 | 0.018 | 0.404 | Sodium/bile acid cotransporter inhibitor | 0.391 0.02 DBMET00115 0.398 0.017 DBMET00116 0.398 0.017 DBMET00117 0.404 0.016 DBMET00118 0.391 0.02 DBMET00119 0.323 0.06 DBMET02722 | DBMET00118 | |
| 0.433 | 0.06 | 0.447 | Calcium channel L-type activator | 0.414 0.072 DBMET00115 0.447 0.052 DBMET00116 0.447 0.052 DBMET00117 0.435 0.059 DBMET00118 0.414 0.072 DBMET00119 0.297 0.16 DBMET02722 | DBMET00117 | |
| 0.367 | 0.006 | 0.367 | Alpha 1a adrenoreceptor antagonist | 0.328 0.008 DBMET00115 0.267 0.011 DBMET00116 0.267 0.011 DBMET00117 0.249 0.012 DBMET00118 0.328 0.008 DBMET00119 | ||
| 0.369 | 0.009 | 0.395 | Interleukin 6 antagonist | 0.319 0.012 DBMET00115 0.362 0.009 DBMET00116 0.362 0.009 DBMET00117 0.395 0.008 DBMET00118 0.319 0.012 DBMET00119 0.249 0.023 DBMET02722 | DBMET00118 | |
| 0.335 | 0.005 | 0.335 | Alpha 1d adrenoreceptor antagonist | 0.319 0.005 DBMET00115 0.233 0.008 DBMET00116 0.233 0.008 DBMET00117 0.202 0.009 DBMET00118 0.319 0.005 DBMET00119 | ||
| 0.338 | 0.01 | 0.379 | Insulin sensitizer | 0.283 0.02 DBMET00115 0.337 0.01 DBMET00116 0.337 0.01 DBMET00117 0.379 0.007 DBMET00118 0.283 0.02 DBMET00119 0.22 0.055 DBMET02722 | DBMET00118 | |
| 0.33 | 0.006 | 0.33 | Alpha 1b adrenoreceptor antagonist | 0.319 0.007 DBMET00115 0.252 0.01 DBMET00116 0.252 0.01 DBMET00117 0.242 0.011 DBMET00118 0.319 0.007 DBMET00119 | ||
| 0.339 | 0.016 | 0.374 | DNA methyltransferase I inhibitor | 0.327 0.018 DBMET00115 0.374 0.011 DBMET00116 0.374 0.011 DBMET00117 0.34 0.016 DBMET00118 0.327 0.018 DBMET00119 0.321 0.02 DBMET02722 | DBMET00117 | |
| 0.397 | 0.077 | 0.463 | Histamine release inhibitor | 0.304 0.121 DBMET00115 0.423 0.064 DBMET00116 0.423 0.064 DBMET00117 0.462 0.044 DBMET00118 0.304 0.121 DBMET00119 0.463 0.044 DBMET02722 | DBMET02722 | |
| 0.325 | 0.008 | 0.325 | 5 Hydroxytryptamine 1A antagonist | 0.29 0.009 DBMET00115 0.214 0.014 DBMET00116 0.214 0.014 DBMET00117 0.186 0.016 DBMET00118 0.29 0.009 DBMET00119 | ||
| 0.322 | 0.022 | 0.362 | DNA methylase inhibitor | 0.303 0.027 DBMET00115 0.346 0.017 DBMET00116 0.346 0.017 DBMET00117 0.324 0.022 DBMET00118 0.303 0.027 DBMET00119 0.362 0.015 DBMET02722 | DBMET02722 | |
| 0.33 | 0.042 | 0.376 | Interleukin antagonist | 0.279 0.053 DBMET00115 0.376 0.034 DBMET00116 0.376 0.034 DBMET00117 0.375 0.035 DBMET00118 0.279 0.053 DBMET00119 | DBMET00117 | |
| 0.29 | 0.005 | 0.29 | Calcium antagonist | 0.184 0.015 DBMET00115 0.184 0.015 DBMET00116 0.184 0.015 DBMET00117 0.169 0.018 DBMET00118 0.184 0.015 DBMET00119 | ||
| 0.377 | 0.093 | 0.378 | 5 Hydroxytryptamine release inhibitor | 0.3 0.165 DBMET00115 0.378 0.092 DBMET00116 0.378 0.092 DBMET00117 0.351 0.114 DBMET00118 0.3 0.165 DBMET00119 0.324 0.14 DBMET02722 | DBMET00117 | |
| 0.288 | 0.008 | 0.314 | Topoisomerase II alpha inhibitor | 0.281 0.008 DBMET00115 0.314 0.006 DBMET00116 0.314 0.006 DBMET00117 0.314 0.006 DBMET00118 0.281 0.008 DBMET00119 0.278 0.009 DBMET02722 | DBMET00118 | |
| 0.289 | 0.014 | 0.318 | Insulin secretagoues | 0.219 0.028 DBMET00115 0.264 0.017 DBMET00116 0.264 0.017 DBMET00117 0.318 0.01 DBMET00118 0.219 0.028 DBMET00119 0.261 0.018 DBMET02722 | DBMET00118 | |
| 0.376 | 0.105 | 0.607 | Cyclophilin D inhibitor | 0.344 0.127 DBMET00115 0.378 0.104 DBMET00116 0.378 0.104 DBMET00117 0.444 0.069 DBMET00118 0.344 0.127 DBMET00119 0.607 0.026 DBMET02722 | DBMET02722 | |
| 0.285 | 0.014 | 0.299 | Anesthetic local | 0.297 0.013 DBMET00115 0.273 0.016 DBMET00116 0.273 0.016 DBMET00117 0.299 0.012 DBMET00118 0.297 0.013 DBMET00119 | DBMET00118 | |
| 0.308 | 0.048 | 0.375 | Superoxide dismutase inhibitor | 0.258 0.07 DBMET00115 0.375 0.031 DBMET00116 0.375 0.031 DBMET00117 0.344 0.038 DBMET00118 0.258 0.07 DBMET00119 | DBMET00117 | |
| 0.267 | 0.012 | 0.267 | 5 Hydroxytryptamine 1 antagonist | 0.224 0.015 DBMET00115 0.16 0.022 DBMET00116 0.16 0.022 DBMET00117 0.143 0.025 DBMET00118 0.224 0.015 DBMET00119 | ||
| 0.305 | 0.051 | 0.332 | Transcription factor STAT3 inhibitor | 0.273 0.068 DBMET00115 0.323 0.043 DBMET00116 0.323 0.043 DBMET00117 0.332 0.039 DBMET00118 0.273 0.068 DBMET00119 | DBMET00118 | |
| 0.249 | 0.015 | 0.249 | Alpha 2b adrenoreceptor antagonist | 0.163 0.034 DBMET00115 0.202 0.023 DBMET00116 0.202 0.023 DBMET00117 0.224 0.019 DBMET00118 0.163 0.034 DBMET00119 | ||
| 0.242 | 0.02 | 0.254 | 5 Hydroxytryptamine 3E antagonist | 0.198 0.065 DBMET00115 0.198 0.065 DBMET00116 0.198 0.065 DBMET00117 0.254 0.014 DBMET00118 0.198 0.065 DBMET00119 | DBMET00118 | |
| 0.273 | 0.051 | 0.273 | Psychostimulant | 0.237 0.063 DBMET00115 0.267 0.053 DBMET00116 0.267 0.053 DBMET00117 0.27 0.051 DBMET00118 0.237 0.063 DBMET00119 0.172 0.098 DBMET02722 | ||
| 0.278 | 0.061 | 0.528 | Hypoglycemic | 0.241 0.082 DBMET00115 0.316 0.048 DBMET00116 0.316 0.048 DBMET00117 0.325 0.045 DBMET00118 0.241 0.082 DBMET00119 0.528 0.013 DBMET02722 | DBMET02722 | |
| 0.294 | 0.082 | 0.36 | Caspase 3 stimulant | 0.309 0.074 DBMET00115 0.36 0.056 DBMET00116 0.36 0.056 DBMET00117 0.302 0.077 DBMET00118 0.309 0.074 DBMET00119 0.315 0.072 DBMET02722 | DBMET00117 | |
| 0.302 | 0.093 | 0.64 | Transcription factor NF kappa B inhibitor | 0.287 0.102 DBMET00115 0.412 0.061 DBMET00116 0.412 0.061 DBMET00117 0.366 0.072 DBMET00118 0.287 0.102 DBMET00119 0.64 0.027 DBMET02722 | DBMET02722 | |
| 0.231 | 0.027 | 0.306 | Topoisomerase II inhibitor | 0.281 0.02 DBMET00115 0.278 0.02 DBMET00116 0.278 0.02 DBMET00117 0.275 0.021 DBMET00118 0.281 0.02 DBMET00119 0.306 0.017 DBMET02722 | DBMET02722 | |
| 0.295 | 0.094 | 0.524 | Cholesterol antagonist | 0.245 0.129 DBMET00115 0.28 0.105 DBMET00116 0.28 0.105 DBMET00117 0.343 0.067 DBMET00118 0.245 0.129 DBMET00119 0.524 0.029 DBMET02722 | DBMET02722 | |
| 0.28 | 0.079 | 0.302 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.278 0.082 DBMET00115 0.277 0.083 DBMET00116 0.277 0.083 DBMET00117 0.302 0.063 DBMET00118 0.278 0.082 DBMET00119 | DBMET00118 | |
| 0.214 | 0.015 | 0.214 | Alpha 2 adrenoreceptor antagonist | 0.174 0.022 DBMET00115 0.173 0.022 DBMET00116 0.173 0.022 DBMET00117 0.21 0.016 DBMET00118 0.174 0.022 DBMET00119 | ||
| 0.258 | 0.061 | 0.324 | Tyrosine 3 hydroxylase inhibitor | 0.246 0.072 DBMET00115 0.278 0.046 DBMET00116 0.278 0.046 DBMET00117 0.324 0.023 DBMET00118 0.246 0.072 DBMET00119 | DBMET00118 | |
| 0.212 | 0.023 | 0.38 | Alkylator | 0.289 0.013 DBMET00115 0.226 0.02 DBMET00116 0.226 0.02 DBMET00117 0.217 0.022 DBMET00118 0.289 0.013 DBMET00119 0.38 0.008 DBMET02722 | DBMET02722 | |
| 0.204 | 0.022 | 0.226 | Toll-Like receptor 2 antagonist | 0.195 0.026 DBMET00115 0.216 0.017 DBMET00116 0.216 0.017 DBMET00117 0.226 0.014 DBMET00118 0.195 0.026 DBMET00119 0.105 0.097 DBMET02722 | DBMET00118 | |
| 0.2 | 0.019 | 0.2 | Nav1.6 sodium channel blocker | 0.146 0.058 DBMET00115 0.175 0.032 DBMET00116 0.175 0.032 DBMET00117 0.177 0.03 DBMET00118 0.146 0.058 DBMET00119 | ||
| 0.2 | 0.024 | 0.2 | Nav1.3 sodium channel blocker | 0.119 0.075 DBMET00115 0.149 0.048 DBMET00116 0.149 0.048 DBMET00117 0.159 0.042 DBMET00118 0.119 0.075 DBMET00119 | ||
| 0.177 | 0.003 | 0.34 | Beta adrenoreceptor agonist | 0.34 0.002 DBMET00115 0.247 0.002 DBMET00116 0.247 0.002 DBMET00117 0.335 0.002 DBMET00118 0.34 0.002 DBMET00119 | DBMET00119 | |
| 0.198 | 0.027 | 0.282 | Topoisomerase I inhibitor | 0.267 0.014 DBMET00115 0.224 0.021 DBMET00116 0.224 0.021 DBMET00117 0.229 0.02 DBMET00118 0.267 0.014 DBMET00119 0.282 0.013 DBMET02722 | DBMET02722 | |
| 0.195 | 0.027 | 0.218 | DNA intercalator | 0.218 0.021 DBMET00115 0.19 0.029 DBMET00116 0.19 0.029 DBMET00117 0.203 0.025 DBMET00118 0.218 0.021 DBMET00119 0.204 0.024 DBMET02722 | DBMET00119 | |
| 0.321 | 0.158 | 0.554 | Apoptosis agonist | 0.35 0.138 DBMET00115 0.399 0.114 DBMET00116 0.399 0.114 DBMET00117 0.369 0.129 DBMET00118 0.35 0.138 DBMET00119 0.554 0.059 DBMET02722 | DBMET02722 | |
| 0.165 | 0.002 | 0.332 | Beta 3 adrenoreceptor agonist | 0.304 0.002 DBMET00115 0.215 0.002 DBMET00116 0.215 0.002 DBMET00117 0.332 0.002 DBMET00118 0.304 0.002 DBMET00119 | DBMET00118 | |
| 0.229 | 0.067 | 0.35 | Peptidyltransferase inhibitor | 0.222 0.074 DBMET00115 0.232 0.065 DBMET00116 0.232 0.065 DBMET00117 0.264 0.042 DBMET00118 0.222 0.074 DBMET00119 0.35 0.012 DBMET02722 | DBMET02722 | |
| 0.224 | 0.067 | 0.224 | ErbB-1 antagonist | 0.203 0.086 DBMET00115 0.218 0.072 DBMET00116 0.218 0.072 DBMET00117 0.198 0.091 DBMET00118 0.203 0.086 DBMET00119 | ||
| 0.179 | 0.027 | 0.179 | MAP3K9 inhibitor | 0.165 0.04 DBMET00115 0.174 0.031 DBMET00116 0.174 0.031 DBMET00117 0.174 0.032 DBMET00118 0.165 0.04 DBMET00119 | ||
| 0.187 | 0.035 | 0.187 | Calcium channel blocker | 0.122 0.086 DBMET00115 0.129 0.077 DBMET00116 0.129 0.077 DBMET00117 0.131 0.076 DBMET00118 0.122 0.086 DBMET00119 | ||
| 0.216 | 0.066 | 0.239 | Nitric-oxide synthase stimulant | 0.196 0.095 DBMET00115 0.239 0.041 DBMET00116 0.239 0.041 DBMET00117 0.236 0.043 DBMET00118 0.196 0.095 DBMET00119 0.179 0.13 DBMET02722 | DBMET00117 | |
| 0.185 | 0.038 | 0.185 | 5 Hydroxytryptamine antagonist | 0.153 0.048 DBMET00115 0.109 0.071 DBMET00116 0.109 0.071 DBMET00117 0.106 0.074 DBMET00118 0.153 0.048 DBMET00119 | ||
| 0.175 | 0.03 | 0.214 | Adenylate cyclase stimulant | 0.167 0.039 DBMET00115 0.175 0.03 DBMET00116 0.175 0.03 DBMET00117 0.214 0.009 DBMET00118 0.167 0.039 DBMET00119 | DBMET00118 | |
| 0.157 | 0.021 | 0.177 | Breast cancer-resistant protein inhibitor | 0.135 0.03 DBMET00115 0.177 0.017 DBMET00116 0.177 0.017 DBMET00117 0.133 0.031 DBMET00118 0.135 0.03 DBMET00119 | DBMET00117 | |
| 0.272 | 0.138 | 0.298 | Antiobesity | 0.219 0.188 DBMET00115 0.226 0.181 DBMET00116 0.226 0.181 DBMET00117 0.298 0.117 DBMET00118 0.219 0.188 DBMET00119 | DBMET00118 | |
| 0.156 | 0.024 | 0.156 | Gastric antisecretory | 0.114 0.049 DBMET00115 0.132 0.035 DBMET00116 0.132 0.035 DBMET00117 0.139 0.032 DBMET00118 0.114 0.049 DBMET00119 | ||
| 0.136 | 0.005 | 0.14 | 5 Hydroxytryptamine 1B agonist | 0.104 0.006 DBMET00115 0.107 0.006 DBMET00116 0.107 0.006 DBMET00117 0.14 0.004 DBMET00118 0.104 0.006 DBMET00119 | DBMET00118 | |
| 0.158 | 0.029 | 0.158 | Alpha 2c adrenoreceptor antagonist | 0.106 0.06 DBMET00115 0.136 0.039 DBMET00116 0.136 0.039 DBMET00117 0.143 0.035 DBMET00118 0.106 0.06 DBMET00119 | ||
| 0.179 | 0.05 | 0.185 | Cyclin-dependent kinase 3 inhibitor | 0.165 0.068 DBMET00115 0.185 0.044 DBMET00116 0.185 0.044 DBMET00117 0.172 0.058 DBMET00118 0.165 0.068 DBMET00119 | DBMET00117 | |
| 0.317 | 0.19 | 0.317 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.298 0.216 DBMET00118 | ||
| 0.174 | 0.047 | 0.193 | GABA C receptor rho-2 antagonist | 0.144 0.083 DBMET00115 0.193 0.033 DBMET00116 0.193 0.033 DBMET00117 0.168 0.053 DBMET00118 0.144 0.083 DBMET00119 | DBMET00117 | |
| 0.205 | 0.079 | 0.211 | MAP kinase kinase 2 inhibitor | 0.171 0.103 DBMET00115 0.204 0.079 DBMET00116 0.204 0.079 DBMET00117 0.211 0.075 DBMET00118 0.171 0.103 DBMET00119 | DBMET00118 | |
| 0.228 | 0.104 | 0.275 | Transcription factor STAT inhibitor | 0.196 0.144 DBMET00115 0.256 0.083 DBMET00116 0.256 0.083 DBMET00117 0.275 0.07 DBMET00118 0.196 0.144 DBMET00119 | DBMET00118 | |
| 0.163 | 0.041 | 0.17 | MAP kinase kinase 4 inhibitor | 0.157 0.049 DBMET00115 0.169 0.034 DBMET00116 0.169 0.034 DBMET00117 0.17 0.032 DBMET00118 0.157 0.049 DBMET00119 | DBMET00118 | |
| 0.198 | 0.079 | 0.336 | Amyloid beta aggregation inhibitor | 0.336 0.038 DBMET00115 0.297 0.046 DBMET00116 0.297 0.046 DBMET00117 0.294 0.046 DBMET00118 0.336 0.038 DBMET00119 0.243 0.06 DBMET02722 | DBMET00119 | |
| 0.14 | 0.022 | 0.14 | ALK inhibitor | 0.116 0.032 DBMET00115 0.121 0.029 DBMET00116 0.121 0.029 DBMET00117 0.12 0.03 DBMET00118 0.116 0.032 DBMET00119 | ||
| 0.167 | 0.051 | 0.183 | Tubulin antagonist | 0.177 0.046 DBMET00115 0.183 0.043 DBMET00116 0.183 0.043 DBMET00117 0.137 0.065 DBMET00118 0.177 0.046 DBMET00119 | DBMET00117 | |
| 0.151 | 0.037 | 0.157 | Vanilloid 1 agonist | 0.142 0.047 DBMET00115 0.156 0.033 DBMET00116 0.156 0.033 DBMET00117 0.157 0.032 DBMET00118 0.142 0.047 DBMET00119 0.14 0.049 DBMET02722 | DBMET00118 | |
| 0.117 | 0.003 | 0.118 | Calcium-sensing receptor antagonist | 0.11 0.003 DBMET00115 0.101 0.004 DBMET00116 0.101 0.004 DBMET00117 0.118 0.003 DBMET00118 0.11 0.003 DBMET00119 | DBMET00118 | |
| 0.126 | 0.014 | 0.126 | Calcium channel L-type blocker | 0.082 0.038 DBMET00115 0.088 0.032 DBMET00116 0.088 0.032 DBMET00117 0.089 0.031 DBMET00118 0.082 0.038 DBMET00119 | ||
| 0.119 | 0.012 | 0.119 | Phosphodiesterase VI inhibitor | 0.088 0.031 DBMET00115 0.117 0.013 DBMET00116 0.117 0.013 DBMET00117 0.105 0.017 DBMET00118 0.088 0.031 DBMET00119 0.104 0.018 DBMET02722 | ||
| 0.142 | 0.036 | 0.162 | Protein kinase C gamma inhibitor | 0.107 0.066 DBMET00115 0.154 0.029 DBMET00116 0.154 0.029 DBMET00117 0.162 0.025 DBMET00118 0.107 0.066 DBMET00119 | DBMET00118 | |
| 0.119 | 0.015 | 0.119 | Phosphodiesterase III inhibitor | 0.1 0.022 DBMET00115 0.109 0.019 DBMET00116 0.109 0.019 DBMET00117 0.104 0.021 DBMET00118 0.1 0.022 DBMET00119 | ||
| 0.17 | 0.069 | 0.364 | Peroxidase inhibitor | 0.151 0.077 DBMET00115 0.327 0.032 DBMET00116 0.327 0.032 DBMET00117 0.364 0.026 DBMET00118 0.151 0.077 DBMET00119 | DBMET00118 | |
| 0.133 | 0.032 | 0.184 | Toll-Like receptor 4 antagonist | 0.125 0.038 DBMET00115 0.14 0.027 DBMET00116 0.14 0.027 DBMET00117 0.135 0.03 DBMET00118 0.125 0.038 DBMET00119 0.184 0.009 DBMET02722 | DBMET02722 | |
| 0.153 | 0.054 | 0.162 | Toll-Like receptor antagonist | 0.114 0.095 DBMET00115 0.131 0.071 DBMET00116 0.131 0.071 DBMET00117 0.162 0.048 DBMET00118 0.114 0.095 DBMET00119 | DBMET00118 | |
| 0.104 | 0.006 | 0.112 | Sphingosine 1-phosphate receptor 3 agonist | 0.08 0.008 DBMET00115 0.085 0.008 DBMET00116 0.085 0.008 DBMET00117 0.112 0.005 DBMET00118 0.08 0.008 DBMET00119 | DBMET00118 | |
| 0.12 | 0.025 | 0.14 | Phosphodiesterase 6D inhibitor | 0.102 0.049 DBMET00115 0.121 0.024 DBMET00116 0.121 0.024 DBMET00117 0.14 0.013 DBMET00118 0.102 0.049 DBMET00119 0.139 0.013 DBMET02722 | DBMET00118 | |
| 0.126 | 0.03 | 0.134 | MAP kinase kinase 1 inhibitor | 0.084 0.08 DBMET00115 0.106 0.049 DBMET00116 0.106 0.049 DBMET00117 0.134 0.024 DBMET00118 0.084 0.08 DBMET00119 | DBMET00118 | |
| 0.195 | 0.103 | 0.385 | Antiamyloidogenic | 0.245 0.073 DBMET00115 0.262 0.066 DBMET00116 0.262 0.066 DBMET00117 0.223 0.085 DBMET00118 0.245 0.073 DBMET00119 0.385 0.031 DBMET02722 | DBMET02722 | |
| 0.097 | 0.006 | 0.097 | Calcium channel P-type blocker | 0.071 0.026 DBMET00115 0.071 0.026 DBMET00116 0.071 0.026 DBMET00117 0.064 0.042 DBMET00118 0.071 0.026 DBMET00119 | ||
| 0.119 | 0.029 | 0.13 | Alpha 2a adrenoreceptor antagonist | 0.11 0.032 DBMET00115 0.097 0.038 DBMET00116 0.097 0.038 DBMET00117 0.13 0.027 DBMET00118 0.11 0.032 DBMET00119 | DBMET00118 | |
| 0.183 | 0.094 | 0.193 | Antimitotic | 0.181 0.095 DBMET00115 0.193 0.088 DBMET00116 0.193 0.088 DBMET00117 0.148 0.123 DBMET00118 0.181 0.095 DBMET00119 | DBMET00117 | |
| 0.117 | 0.032 | 0.117 | Toll-Like receptor 3 antagonist | 0.095 0.058 DBMET00115 0.095 0.058 DBMET00116 0.095 0.058 DBMET00117 0.097 0.056 DBMET00118 0.095 0.058 DBMET00119 | ||
| 0.089 | 0.005 | 0.124 | Beta 2 adrenoreceptor agonist | 0.124 0.003 DBMET00115 0.104 0.004 DBMET00116 0.104 0.004 DBMET00117 0.123 0.003 DBMET00118 0.124 0.003 DBMET00119 | DBMET00119 | |
| 0.085 | 0.003 | 0.175 | Beta 1 adrenoreceptor agonist | 0.168 0.002 DBMET00115 0.121 0.003 DBMET00116 0.121 0.003 DBMET00117 0.175 0.002 DBMET00118 0.168 0.002 DBMET00119 | DBMET00118 | |
| 0.242 | 0.161 | 0.374 | GABA C receptor rho-3 antagonist | 0.32 0.103 DBMET00116 0.32 0.103 DBMET00117 0.374 0.073 DBMET00118 | DBMET00118 | |
| 0.149 | 0.069 | 0.233 | Lipid peroxidase inhibitor | 0.207 0.039 DBMET00115 0.205 0.04 DBMET00116 0.205 0.04 DBMET00117 0.22 0.034 DBMET00118 0.207 0.039 DBMET00119 0.233 0.03 DBMET02722 | DBMET02722 | |
| 0.119 | 0.041 | 0.12 | GABA C receptor rho-1 antagonist | 0.087 0.084 DBMET00115 0.12 0.039 DBMET00116 0.12 0.039 DBMET00117 0.12 0.04 DBMET00118 0.087 0.084 DBMET00119 | DBMET00118 | |
| 0.161 | 0.084 | 0.249 | ATPase inhibitor | 0.176 0.062 DBMET00115 0.16 0.085 DBMET00116 0.16 0.085 DBMET00117 0.168 0.074 DBMET00118 0.176 0.062 DBMET00119 0.249 0.014 DBMET02722 | DBMET02722 | |
| 0.119 | 0.045 | 0.212 | Bronchodilator | 0.212 0.017 DBMET00115 0.126 0.041 DBMET00116 0.126 0.041 DBMET00117 0.11 0.053 DBMET00118 0.212 0.017 DBMET00119 | DBMET00119 | |
| 0.121 | 0.048 | 0.35 | AMP-activated protein kinase stimulant | 0.114 0.055 DBMET00115 0.143 0.033 DBMET00116 0.143 0.033 DBMET00117 0.152 0.027 DBMET00118 0.114 0.055 DBMET00119 0.35 0.004 DBMET02722 | DBMET02722 | |
| 0.111 | 0.039 | 0.111 | 5 Hydroxytryptamine 2C antagonist | 0.094 0.049 DBMET00115 0.075 0.066 DBMET00116 0.075 0.066 DBMET00117 0.094 0.049 DBMET00119 | ||
| 0.08 | 0.009 | 0.08 | Sphingosine 1-phosphate receptor agonist | 0.045 0.029 DBMET00115 0.054 0.021 DBMET00116 0.054 0.021 DBMET00117 0.07 0.011 DBMET00118 0.045 0.029 DBMET00119 | ||
| 0.182 | 0.113 | 0.462 | Free radical scavenger | 0.249 0.069 DBMET00115 0.302 0.051 DBMET00116 0.302 0.051 DBMET00117 0.306 0.05 DBMET00118 0.249 0.069 DBMET00119 0.462 0.02 DBMET02722 | DBMET02722 | |
| 0.221 | 0.153 | 0.583 | Antithrombotic | 0.216 0.158 DBMET00116 0.216 0.158 DBMET00117 0.254 0.123 DBMET00118 0.583 0.018 DBMET02722 | DBMET02722 | |
| 0.191 | 0.126 | 0.48 | Immunostimulant | 0.176 0.135 DBMET00115 0.216 0.111 DBMET00116 0.216 0.111 DBMET00117 0.253 0.095 DBMET00118 0.176 0.135 DBMET00119 0.48 0.032 DBMET02722 | DBMET02722 | |
| 0.187 | 0.125 | 0.477 | Antioxidant | 0.251 0.083 DBMET00115 0.291 0.065 DBMET00116 0.291 0.065 DBMET00117 0.293 0.064 DBMET00118 0.251 0.083 DBMET00119 0.477 0.023 DBMET02722 | DBMET02722 | |
| 0.074 | 0.013 | 0.074 | Ryanodine receptor antagonist | 0.065 0.025 DBMET00115 0.07 0.018 DBMET00116 0.07 0.018 DBMET00117 0.063 0.029 DBMET00118 0.065 0.025 DBMET00119 | ||
| 0.09 | 0.028 | 0.09 | Fibroblast growth factor 2 antagonist | 0.083 0.032 DBMET00116 0.083 0.032 DBMET00117 | ||
| 0.104 | 0.044 | 0.185 | NMDA receptor antagonist | 0.112 0.04 DBMET00115 0.143 0.026 DBMET00116 0.143 0.026 DBMET00117 0.185 0.017 DBMET00118 0.112 0.04 DBMET00119 | DBMET00118 | |
| 0.117 | 0.057 | 0.123 | Mucolytic | 0.098 0.081 DBMET00115 0.123 0.051 DBMET00116 0.123 0.051 DBMET00117 0.119 0.055 DBMET00118 0.098 0.081 DBMET00119 0.102 0.075 DBMET02722 | DBMET00117 | |
| 0.084 | 0.024 | 0.086 | 5 Hydroxytryptamine 2A agonist | 0.086 0.022 DBMET00115 0.079 0.028 DBMET00116 0.079 0.028 DBMET00117 0.056 0.051 DBMET00118 0.086 0.022 DBMET00119 | DBMET00119 | |
| 0.068 | 0.009 | 0.068 | Sphingosine 1-phosphate receptor 1 agonist | 0.042 0.029 DBMET00115 0.048 0.022 DBMET00116 0.048 0.022 DBMET00117 0.065 0.01 DBMET00118 0.042 0.029 DBMET00119 | ||
| 0.108 | 0.051 | 0.108 | Sphingomyelinase inhibitor | 0.091 0.071 DBMET02722 | ||
| 0.077 | 0.021 | 0.077 | Cyclin D1 inhibitor | 0.072 0.026 DBMET00115 0.077 0.021 DBMET00116 0.077 0.021 DBMET00117 0.061 0.041 DBMET00118 0.072 0.026 DBMET00119 | ||
| 0.091 | 0.037 | 0.128 | Keratolytic | 0.082 0.046 DBMET00115 0.128 0.019 DBMET00116 0.128 0.019 DBMET00117 0.114 0.024 DBMET00118 0.082 0.046 DBMET00119 | DBMET00117 | |
| 0.092 | 0.038 | 0.143 | Telomerase inhibitor | 0.068 0.054 DBMET00115 0.088 0.04 DBMET00116 0.088 0.04 DBMET00117 0.143 0.021 DBMET00118 0.068 0.054 DBMET00119 | DBMET00118 | |
| 0.097 | 0.044 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.093 0.05 DBMET00115 0.093 0.05 DBMET00116 0.093 0.05 DBMET00117 0.098 0.043 DBMET00118 0.093 0.05 DBMET00119 0.104 0.034 DBMET02722 | DBMET02722 | |
| 0.093 | 0.044 | 0.137 | Carbonic anhydrase VI inhibitor | 0.08 0.057 DBMET00115 0.134 0.025 DBMET00116 0.134 0.025 DBMET00117 0.137 0.024 DBMET00118 0.08 0.057 DBMET00119 | DBMET00118 | |
| 0.243 | 0.199 | 0.244 | MAP kinase kinase 6 inhibitor | 0.231 0.216 DBMET00116 0.231 0.216 DBMET00117 0.244 0.198 DBMET00118 | DBMET00118 | |
| 0.105 | 0.061 | 0.105 | Nav1.1 sodium channel blocker | 0.101 0.065 DBMET00116 0.101 0.065 DBMET00117 0.101 0.065 DBMET00118 | ||
| 0.094 | 0.053 | 0.107 | Glutamate release inhibitor | 0.107 0.034 DBMET00115 0.107 0.034 DBMET00119 0.1 0.043 DBMET02722 | DBMET00119 | |
| 0.067 | 0.03 | 0.067 | Alpha 1 adrenoreceptor agonist | 0.06 0.036 DBMET00115 0.056 0.042 DBMET00116 0.056 0.042 DBMET00117 0.059 0.038 DBMET00118 0.06 0.036 DBMET00119 | ||
| 0.089 | 0.053 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | 0.079 0.078 DBMET00115 0.079 0.078 DBMET00116 0.079 0.078 DBMET00117 0.084 0.065 DBMET00118 0.079 0.078 DBMET00119 | ||
| 0.102 | 0.066 | 0.208 | Expectorant | 0.108 0.06 DBMET00116 0.108 0.06 DBMET00117 0.103 0.065 DBMET00118 0.208 0.019 DBMET02722 | DBMET02722 | |
| 0.108 | 0.074 | 0.146 | Photosensitizer | 0.118 0.059 DBMET00116 0.118 0.059 DBMET00117 0.098 0.093 DBMET00118 0.146 0.033 DBMET02722 | DBMET02722 | |
| 0.073 | 0.039 | 0.073 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.147 | 0.114 | 0.177 | Death-associated protein kinase 2 inhibitor | 0.141 0.129 DBMET00115 0.151 0.103 DBMET00116 0.151 0.103 DBMET00117 0.177 0.058 DBMET00118 0.141 0.129 DBMET00119 | DBMET00118 | |
| 0.084 | 0.051 | 0.084 | Phosphodiesterase XI inhibitor | 0.076 0.068 DBMET00116 0.076 0.068 DBMET00117 | ||
| 0.084 | 0.051 | 0.084 | Phosphodiesterase 11A inhibitor | 0.076 0.068 DBMET00116 0.076 0.068 DBMET00117 | ||
| 0.118 | 0.086 | 0.118 | Nav1.2 sodium channel blocker | |||
| 0.096 | 0.066 | 0.14 | Carbonic anhydrase III inhibitor | 0.086 0.081 DBMET00115 0.14 0.033 DBMET00116 0.14 0.033 DBMET00117 0.14 0.032 DBMET00118 0.086 0.081 DBMET00119 | DBMET00118 | |
| 0.117 | 0.086 | 0.12 | Antibacterial (Helicobacter pylori) | 0.116 0.088 DBMET00115 0.117 0.086 DBMET00116 0.117 0.086 DBMET00117 0.12 0.081 DBMET00118 0.116 0.088 DBMET00119 | DBMET00118 | |
| 0.061 | 0.032 | 0.061 | 5 Hydroxytryptamine 1 agonist | |||
| 0.064 | 0.036 | 0.064 | Bombesin 1 receptor agonist | 0.057 0.045 DBMET00115 0.06 0.04 DBMET00116 0.06 0.04 DBMET00117 0.059 0.042 DBMET00118 0.057 0.045 DBMET00119 | ||
| 0.077 | 0.05 | 0.086 | GABA B receptor agonist | 0.082 0.039 DBMET00116 0.082 0.039 DBMET00117 0.086 0.032 DBMET00118 | DBMET00118 | |
| 0.211 | 0.185 | 0.424 | Immunosuppressant | 0.216 0.18 DBMET00116 0.216 0.18 DBMET00117 0.227 0.169 DBMET00118 0.424 0.055 DBMET02722 | DBMET02722 | |
| 0.11 | 0.084 | 0.128 | MAP kinase kinase inhibitor | 0.105 0.089 DBMET00116 0.105 0.089 DBMET00117 0.128 0.066 DBMET00118 | DBMET00118 | |
| 0.151 | 0.127 | 0.173 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.143 0.137 DBMET00116 0.143 0.137 DBMET00117 0.173 0.101 DBMET00118 | DBMET00118 | |
| 0.077 | 0.054 | 0.126 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.126 0.027 DBMET00115 0.117 0.03 DBMET00116 0.117 0.03 DBMET00117 0.095 0.04 DBMET00118 0.126 0.027 DBMET00119 | DBMET00119 | |
| 0.11 | 0.088 | 0.335 | Amylase inhibitor | 0.193 0.047 DBMET00116 0.193 0.047 DBMET00117 0.159 0.06 DBMET00118 0.335 0.014 DBMET02722 | DBMET02722 | |
| 0.083 | 0.062 | 0.1 | Vanilloid agonist | 0.08 0.069 DBMET00115 0.09 0.047 DBMET00116 0.09 0.047 DBMET00117 0.1 0.033 DBMET00118 0.08 0.069 DBMET00119 | DBMET00118 | |
| 0.089 | 0.068 | 0.108 | Protein kinase C zeta inhibitor | 0.104 0.046 DBMET00116 0.104 0.046 DBMET00117 0.108 0.042 DBMET00118 | DBMET00118 | |
| 0.096 | 0.075 | 0.096 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.06 | 0.042 | 0.074 | Dopamine D4 antagonist | 0.074 0.035 DBMET00115 0.053 0.046 DBMET00118 0.074 0.035 DBMET00119 | DBMET00119 | |
| 0.062 | 0.044 | 0.07 | Nitric oxide donor | 0.06 0.049 DBMET00116 0.06 0.049 DBMET00117 0.065 0.04 DBMET00118 0.07 0.032 DBMET02722 | DBMET02722 | |
| 0.1 | 0.083 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.054 | 0.038 | 0.054 | Myc inhibitor | 0.051 0.044 DBMET00116 0.051 0.044 DBMET00117 0.053 0.04 DBMET00118 | ||
| 0.104 | 0.09 | 0.104 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.107 | 0.093 | 0.208 | Cyclooxygenase 3 inhibitor | 0.119 0.078 DBMET00116 0.119 0.078 DBMET00117 0.112 0.086 DBMET00118 0.208 0.016 DBMET02722 | DBMET02722 | |
| 0.079 | 0.066 | 0.141 | Antineoplastic alkaloid | 0.141 0.03 DBMET00115 0.084 0.061 DBMET00116 0.084 0.061 DBMET00117 0.092 0.053 DBMET00118 0.141 0.03 DBMET00119 | DBMET00119 | |
| 0.053 | 0.041 | 0.054 | Epithelial sodium channel blocker | 0.054 0.039 DBMET00118 | DBMET00118 | |
| 0.043 | 0.034 | 0.043 | 5 Hydroxytryptamine 1A agonist | |||
| 0.118 | 0.111 | 0.17 | Acetylcholine M1 receptor antagonist | 0.17 0.058 DBMET00115 0.147 0.077 DBMET00118 0.17 0.058 DBMET00119 | DBMET00119 | |
| 0.023 | 0.017 | 0.029 | Dopamine autoreceptor agonist | 0.029 0.014 DBMET00116 0.029 0.014 DBMET00117 0.026 0.015 DBMET00118 | DBMET00117 | |
| 0.026 | 0.02 | 0.04 | Toll-Like receptor 4 agonist | 0.025 0.024 DBMET00116 0.025 0.024 DBMET00117 0.04 0.005 DBMET02722 | DBMET02722 | |
| 0.045 | 0.043 | 0.045 | Bombesin 2 receptor antagonist | 0.044 0.043 DBMET00116 0.044 0.043 DBMET00117 | ||
| 0.092 | 0.091 | 0.113 | GABA C receptor antagonist | 0.096 0.084 DBMET00116 0.096 0.084 DBMET00117 0.113 0.06 DBMET00118 | DBMET00118 | |
| 0.192 | 0.191 | 0.429 | Apoptosis antagonist | 0.199 0.18 DBMET00115 0.238 0.14 DBMET00116 0.238 0.14 DBMET00117 0.24 0.138 DBMET00118 0.199 0.18 DBMET00119 0.429 0.031 DBMET02722 | DBMET02722 | |
| 0.046 | 0.051 | 0.059 | Protein kinase C eta inhibitor | 0.053 0.04 DBMET00116 0.053 0.04 DBMET00117 0.059 0.035 DBMET00118 0.053 0.04 DBMET02722 | DBMET00118 | |
| 0.076 | 0.082 | 0.083 | Estrogen-related receptor beta agonist | 0.083 0.058 DBMET00116 0.083 0.058 DBMET00117 0.083 0.059 DBMET00118 | DBMET00118 | |
| 0.016 | 0.023 | 0.03 | Antibiotic Anthracycline-like | 0.03 0.004 DBMET02722 | DBMET02722 | |
| 0.058 | 0.065 | 0.067 | Dopamine antagonist | 0.067 0.056 DBMET00115 0.067 0.056 DBMET00119 | DBMET00119 | |
| 0.051 | 0.059 | 0.079 | Heat shock protein 90 beta antagonist | 0.074 0.025 DBMET00115 0.079 0.021 DBMET00116 0.079 0.021 DBMET00117 0.069 0.029 DBMET00118 0.074 0.025 DBMET00119 | DBMET00117 | |
| 0.054 | 0.063 | 0.063 | Alpha adrenoreceptor agonist | 0.063 0.052 DBMET00118 | DBMET00118 | |
| 0.075 | 0.086 | 0.117 | MAO A inhibitor | 0.084 0.076 DBMET00115 0.117 0.054 DBMET00116 0.117 0.054 DBMET00117 0.099 0.065 DBMET00118 0.084 0.076 DBMET00119 | DBMET00117 | |
| 0.011 | 0.022 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 DBMET02722 | DBMET02722 | |
| 0.07 | 0.082 | 0.082 | MAP kinase kinase 7 inhibitor | 0.078 0.051 DBMET00116 0.078 0.051 DBMET00117 0.082 0.04 DBMET00118 | DBMET00118 | |
| 0.091 | 0.103 | 0.101 | CDC-like kinase 3 inhibitor | 0.101 0.078 DBMET00115 0.101 0.078 DBMET00119 | DBMET00119 | |
| 0.12 | 0.135 | 0.153 | Melanin inhibitor | 0.153 0.078 DBMET00116 0.153 0.078 DBMET00117 0.131 0.112 DBMET00118 0.145 0.088 DBMET02722 | DBMET00117 | |
| 0.131 | 0.152 | 0.143 | Succinate dehydrogenase inhibitor | 0.143 0.126 DBMET00118 | DBMET00118 | |
| 0.068 | 0.089 | 0.084 | Myeloperoxidase inhibitor | 0.084 0.059 DBMET00116 0.084 0.059 DBMET00117 0.082 0.063 DBMET00118 | DBMET00117 | |
| 0.063 | 0.087 | 0.085 | Ornithine decarboxylase inhibitor | 0.085 0.062 DBMET00118 | DBMET00118 | |
| 0.042 | 0.069 | 0.051 | Vanilloid 2 antagonist | 0.051 0.039 DBMET00118 | DBMET00118 | |
| 0.048 | 0.078 | 0.13 | Phenylalanine 4-hydroxylase inhibitor | 0.13 0.016 DBMET00118 | DBMET00118 | |
| 0.024 | 0.055 | 0.035 | Estrogen-related receptor beta antagonist | 0.035 0.017 DBMET00116 0.035 0.017 DBMET00117 | DBMET00117 | |
| 0.087 | 0.117 | 0.114 | Microtubule formation inhibitor | 0.114 0.069 DBMET02722 | DBMET02722 | |
| 0.1 | 0.131 | 0.173 | DNA repair enzyme inhibitor | 0.173 0.016 DBMET02722 | DBMET02722 | |
| 0.065 | 0.097 | 0.087 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.087 0.052 DBMET00115 0.087 0.052 DBMET00119 | DBMET00119 | |
| 0.105 | 0.137 | 0.123 | Phospholipase A2 inhibitor | 0.123 0.112 DBMET00118 | DBMET00118 | |
| 0.026 | 0.059 | 0.062 | Antibiotic Aminoglycoside-like | 0.062 0.008 DBMET02722 | DBMET02722 | |
| 0.042 | 0.076 | 0.084 | Dopamine agonist | 0.08 0.037 DBMET00115 0.084 0.035 DBMET00118 0.08 0.037 DBMET00119 | DBMET00118 | |
| 0.141 | 0.176 | 0.168 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.168 0.112 DBMET00116 0.168 0.112 DBMET00117 0.156 0.136 DBMET00118 | DBMET00117 | |
| 0.026 | 0.062 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.028 DBMET02722 | DBMET02722 | |
| 0.129 | 0.165 | 0.146 | Catenin beta inhibitor | 0.146 0.114 DBMET00116 0.146 0.114 DBMET00117 | DBMET00117 | |
| 0.039 | 0.075 | 0.052 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.045 DBMET00118 | DBMET00118 | |
| 0.127 | 0.164 | 0.205 | Hypolipemic | 0.205 0.09 DBMET02722 | DBMET02722 | |
| 0.128 | 0.166 | 0.142 | Neurotensin receptor agonist | 0.142 0.122 DBMET00116 0.142 0.122 DBMET00117 | DBMET00117 | |
| 0.112 | 0.156 | 0.326 | Platelet adhesion inhibitor | 0.131 0.13 DBMET00116 0.131 0.13 DBMET00117 0.326 0.026 DBMET02722 | DBMET02722 | |
| 0.022 | 0.067 | 0.054 | Dopamine D2 agonist | 0.054 0.024 DBMET00115 0.047 0.029 DBMET00118 0.054 0.024 DBMET00119 | DBMET00119 | |
| 0.016 | 0.062 | 0.048 | Sodium/glucose cotransporter inhibitor | 0.048 0.005 DBMET02722 | DBMET02722 | |
| 0.036 | 0.086 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.046 DBMET02722 | DBMET02722 | |
| 0.077 | 0.129 | 0.122 | Multidrug resistance-associated protein 1 inhibitor | 0.122 0.046 DBMET02722 | DBMET02722 | |
| 0.035 | 0.087 | 0.299 | Selectin antagonist | 0.055 0.054 DBMET00118 0.299 0.005 DBMET02722 | DBMET02722 | |
| 0.013 | 0.068 | 0.048 | Sodium/glucose cotransporter 2 inhibitor | 0.048 0.007 DBMET02722 | DBMET02722 | |
| 0.122 | 0.179 | 0.156 | Phospholipase C inhibitor | 0.156 0.095 DBMET00118 | DBMET00118 | |
| 0.025 | 0.084 | 0.041 | Mannosidase inhibitor | 0.041 0.038 DBMET02722 | DBMET02722 | |
| 0.123 | 0.181 | 0.238 | Platelet antagonist | 0.238 0.078 DBMET02722 | DBMET02722 | |
| 0.079 | 0.14 | 0.11 | Alpha-N-acetylglucosaminidase inhibitor | 0.11 0.088 DBMET00118 0.108 0.09 DBMET02722 | DBMET00118 | |
| 0.083 | 0.144 | 0.128 | Estrogen antagonist | 0.106 0.083 DBMET00115 0.128 0.041 DBMET00116 0.128 0.041 DBMET00117 0.115 0.064 DBMET00118 0.106 0.083 DBMET00119 | DBMET00117 | |
| 0.063 | 0.126 | 0.115 | NADH dehydrogenase inhibitor | 0.115 0.031 DBMET02722 | DBMET02722 | |
| 0.013 | 0.076 | 0.035 | Protein 30S ribosomal subunit inhibitor | 0.035 0.011 DBMET02722 | DBMET02722 | |
| 0.126 | 0.193 | 0.358 | Tumour necrosis factor alpha release inhibitor | 0.358 0.036 DBMET02722 | DBMET02722 | |
| 0.144 | 0.216 | 0.291 | DNA synthesis inhibitor | 0.172 0.165 DBMET00115 0.172 0.165 DBMET00119 0.291 0.047 DBMET02722 | DBMET02722 | |
| 0.12 | 0.191 | 0.179 | Neurotrophic factor enhancer | 0.157 0.127 DBMET00116 0.157 0.127 DBMET00117 0.179 0.099 DBMET00118 | DBMET00118 | |
| 0.034 | 0.108 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.047 DBMET00118 | DBMET00118 | |
| 0.101 | 0.175 | 0.31 | Nitric oxide antagonist | 0.137 0.109 DBMET00116 0.137 0.109 DBMET00117 0.31 0.039 DBMET02722 | DBMET02722 | |
| 0.056 | 0.133 | 0.112 | Mediator release inhibitor | 0.112 0.056 DBMET02722 | DBMET02722 | |
| 0.039 | 0.117 | 0.072 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 DBMET02722 | DBMET02722 | |
| 0.06 | 0.139 | 0.116 | UDP-glucose 4-epimerase inhibitor | 0.092 0.07 DBMET00118 0.116 0.046 DBMET02722 | DBMET02722 | |
| 0.034 | 0.114 | 0.155 | Antineoplastic antibiotic | 0.155 0.03 DBMET02722 | DBMET02722 | |
| 0.037 | 0.118 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.046 DBMET00118 | DBMET00118 | |
| 0.024 | 0.106 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.037 DBMET02722 | DBMET02722 | |
| 0.058 | 0.142 | 0.082 | Triose-phosphate isomerase inhibitor | 0.082 0.073 DBMET02722 | DBMET02722 | |
| 0.103 | 0.188 | 0.357 | Hepatoprotectant | 0.136 0.126 DBMET00116 0.136 0.126 DBMET00117 0.357 0.018 DBMET02722 | DBMET02722 | |
| 0.063 | 0.151 | 0.136 | DNA polymerase I inhibitor | 0.105 0.081 DBMET00115 0.11 0.076 DBMET00118 0.105 0.081 DBMET00119 0.136 0.057 DBMET02722 | DBMET02722 | |
| 0.083 | 0.18 | 0.489 | Angiogenesis stimulant | 0.138 0.13 DBMET00116 0.138 0.13 DBMET00117 0.489 0.012 DBMET02722 | DBMET02722 | |
| 0.058 | 0.157 | 0.111 | Chelator | 0.108 0.067 DBMET00115 0.095 0.085 DBMET00116 0.095 0.085 DBMET00117 0.111 0.063 DBMET00118 0.108 0.067 DBMET00119 | DBMET00118 | |
| 0.076 | 0.178 | 0.099 | Interleukin 8 antagonist | 0.099 0.098 DBMET00118 | DBMET00118 | |
| 0.034 | 0.14 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.03 DBMET02722 | DBMET02722 | |
| 0.062 | 0.169 | 0.161 | Beta glucuronidase inhibitor | 0.161 0.021 DBMET02722 | DBMET02722 | |
| 0.097 | 0.208 | 0.15 | Interferon gamma antagonist | 0.15 0.078 DBMET02722 | DBMET02722 | |
| 0.058 | 0.173 | 0.115 | Adenylate cyclase inhibitor | 0.115 0.072 DBMET00118 | DBMET00118 | |
| 0.057 | 0.178 | 0.085 | Xanthine oxidase inhibitor | 0.085 0.081 DBMET02722 | DBMET02722 | |
| 0.028 | 0.151 | 0.087 | Heparanase inhibitor | 0.087 0.005 DBMET02722 | DBMET02722 | |
| 0.143 | 0.268 | 0.184 | Insulysin inhibitor | 0.184 0.182 DBMET00118 | DBMET00118 | |
| 0.063 | 0.193 | 0.211 | Thrombolytic | 0.211 0.047 DBMET02722 | DBMET02722 | |
| 0.02 | 0.154 | 0.06 | Neuraminidase inhibitor | 0.06 0.043 DBMET02722 | DBMET02722 | |
| 0.067 | 0.212 | 0.116 | Interleukin 4 antagonist | 0.116 0.092 DBMET00116 0.116 0.092 DBMET00117 0.112 0.098 DBMET02722 | DBMET00117 | |
| 0.057 | 0.21 | 0.108 | Alkaline phosphatase inhibitor | 0.108 0.103 DBMET02722 | DBMET02722 | |
| 0.136 | 0.29 | 0.219 | 15-Lipoxygenase inhibitor | 0.208 0.205 DBMET00115 0.219 0.193 DBMET00116 0.219 0.193 DBMET00117 0.218 0.193 DBMET00118 0.208 0.205 DBMET00119 | DBMET00117 | |
| 0.122 | 0.285 | 0.259 | Angiogenesis inhibitor | 0.259 0.117 DBMET02722 | DBMET02722 | |
| 0.018 | 0.184 | 0.084 | Protein 50S ribosomal subunit inhibitor | 0.084 0.018 DBMET02722 | DBMET02722 | |
| 0.024 | 0.201 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.027 DBMET02722 | DBMET02722 | |
| 0.073 | 0.266 | 0.226 | Interleukin agonist | 0.226 0.098 DBMET02722 | DBMET02722 | |
| 0.024 | 0.232 | 0.12 | Monophenol monooxygenase inhibitor | 0.12 0.061 DBMET02722 | DBMET02722 | |
| 0.047 | 0.26 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.034 DBMET02722 | DBMET02722 | |
| 0.129 | 0.362 | 0.388 | Interleukin 2 agonist | 0.388 0.031 DBMET02722 | DBMET02722 | |
| 0.039 | 0.28 | 0.1 | Estrogen receptor beta antagonist | 0.1 0.065 DBMET00116 0.1 0.065 DBMET00117 | DBMET00117 | |
| 0.029 | 0.29 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.014 DBMET02722 | DBMET02722 | |
| 0.11 | 0.376 | 0.533 | Antibacterial | 0.533 0.032 DBMET02722 | DBMET02722 | |
| 0.021 | 0.293 | 0.049 | Factor IXa inhibitor | 0.049 0.039 DBMET02722 | DBMET02722 | |
| 0.1 | 0.387 | 0.327 | Toll-Like receptor agonist | 0.327 0.094 DBMET00115 0.327 0.094 DBMET00119 | DBMET00119 | |
| 0.097 | 0.397 | 0.321 | Toll-Like receptor 7 agonist | 0.321 0.097 DBMET00115 0.321 0.097 DBMET00119 | DBMET00119 | |
| 0.062 | 0.404 | 0.282 | Alpha-glucosidase inhibitor | 0.282 0.169 DBMET02722 | DBMET02722 | |
| 0.051 | 0.403 | 0.2 | Hemostatic | 0.2 0.033 DBMET02722 | DBMET02722 | |
| 0.033 | 0.443 | 0.114 | Cell adhesion inhibitor | 0.114 0.07 DBMET02722 | DBMET02722 | |
| 0.065 | 0.503 | 0.278 | Immunomodulator | 0.278 0.095 DBMET02722 | DBMET02722 | |
| 0.02 | 0.539 | 0.13 | Anticoagulant | 0.13 0.101 DBMET02722 | DBMET02722 | |
| 0.035 | 0.659 | 0.126 | NOS3 expression enhancer | 0.126 0.104 DBMET02722 | DBMET02722 | |
| 0.027 | 0.782 | 0.44 | Antiinflammatory | 0.44 0.115 DBMET02722 | DBMET02722 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |